Radar · Industry landscape · Switzerland
Life Sciences Industry Landscape of Switzerland
1,129 Life Sciences companies in Switzerland, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated September 2026.
1,129companies tracked
$13Bdisclosed funding
79hiring right now
677events · 24 months
279,795news articles · 12 months
Who leads Life Sciences in Switzerland
Shows the 1,129 Swiss life‑sciences firms and highlights which companies are hiring, best funded, or most covered, including 79 current hires and 345 firms that disclosed a funding round.
open roles
Hiring now
ranked by live open roles
- 01
Galderma13last posted Aug 2026
- 02
Sentec8last posted Jun 2026
- 03
Straumann Group8last posted Jul 2026
- 04
Unilabs7last posted Jun 2026
- 05
Hamilton Medical7last posted Jun 2026
- 06
Ypsomed6last posted Jan 2026
- 07
Nanolive5last posted Jul 2026
- 08
Sanoptis5last posted May 2026
79 companies hiring · 1 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
- 01
CRISPR Therapeutics$1.1BPost IPO · Dec 2023
- 02
ADC Therapeutics$691MPost IPO · May 2021
- 03
CeQur$391.6MSeries D · Jan 2025
- 04
Distalmotion$390MSeries G · Jan 2026
- 05
Alentis Therapeutics$365.7MSeries D · Nov 2024
- 06
Windward Bio$365MSeries B · May 2026
- 07
MindMaze Therapeutics$360.6MSeries B · Feb 2022
- 08
SkyCell$270MSeries D · Jun 2024
345 companies with disclosed rounds · $13B total
revenue
Revenue leaders
official filings first, else latest snapshot
- 01
Biotech Healthcare$38.6MFY2022 filing
- 02
Phonak$21.6Msnapshot Mar 2025
- 03
ObsEva$19.6MFY2022 filing
- 04
- 05
- 06
Neovii$2.7MFY2019 filing
- 07
- 08
Muvon Therapeutics$183ksnapshot Dec 2022
9 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
- 01
Octapharma2,697tracked employees
- 02
Tecan2,318tracked employees
- 03
Medartis858tracked employees
- 04
- 05
Inpeco544tracked employees
- 06
- 07
SHL Group444tracked employees
- 08
AliveDx432tracked employees
113 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
- 01
- 02
Alexion5.6%58 tracked events
- 03
- 04
Gain Therapeutics4.3%45 tracked events
- 05
Basilea4.1%43 tracked events
- 06
Syngenta3.9%40 tracked events
- 07
Santhera3.8%39 tracked events
- 08
1,038 tracked events across 122 companies
web reach
Most-used apps
the sites in this sector the web visits most
- 01
Nitec Pharmatop 50khugedomains.com
- 02
- 03
Medelatop 500kmedela.com
- 04
- 05
ExPASytop 500kexpasy.org
- 06
Heybeetop 1Mheybee.com
- 07
Mybacstop 1Mmybacs.com
- 08
279 companies here run a site with a measured audience · 15 of them sit inside the web’s top million
articles
In the news
Prism news coverage, last 12 months
- 01
- 02
MPC155articles in the window
- 03
- 04
Bioversys48articles in the window
- 05
- 06
Oculis36articles in the window
- 07
Molecular Partners32articles in the window
- 08
Naviswiss32articles in the window
100 of these companies drew sector coverage in the window
Radar
See all 1,129 Life Sciences companies in Switzerland
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in Switzerland grew, 2016–2025
Displays the number of companies founded each year from 2016 to 2025, with the highest count of 65 in 2017 and only 9 founded in 2025.
Companies founded / year
new Life Sciences companies in Switzerland
20162025
peak 65 in 2017
Companies raising / year
with a disclosed round that year
20162025
peak 80 in 2022
Disclosed funding / year
sum of disclosed rounds (USD)
20162025
peak $2.3B in 2021
Where Life Sciences companies in Switzerland are based
Lists the cities where these firms are located, with Zurich hosting 164 companies, Basel 121, Lausanne 91, Geneva 66, and Schlieren 44.
Hub 01
Zurich
164 Life Sciences companies
29% of the Life Sciences companies across these hubs
164companies
$2Bdisclosed funding
15hiring now
Hub 02
Basel
121 Life Sciences companies
22% of the Life Sciences companies across these hubs
121companies
$3.9Bdisclosed funding
12hiring now
Hub 03
Lausanne
91 Life Sciences companies
16% of the Life Sciences companies across these hubs
91companies
$1.2Bdisclosed funding
8hiring now
Hub 04
Geneva
66 Life Sciences companies
12% of the Life Sciences companies across these hubs
66companies
$851.9Mdisclosed funding
5hiring now
Hub 05
Schlieren
44 Life Sciences companies
8% of the Life Sciences companies across these hubs
44companies
$919.4Mdisclosed funding
1hiring now
generated artwork
Hub 06
Zug
29 Life Sciences companies
5% of the Life Sciences companies across these hubs
29companies
$608.2Mdisclosed funding
4hiring now
Hub 07
Epalinges
24 Life Sciences companies
4% of the Life Sciences companies across these hubs
24companies
$1.3Bdisclosed funding
2hiring now
generated artwork
Hub 08
Bern
21 Life Sciences companies
4% of the Life Sciences companies across these hubs
21companies
$54.9Mdisclosed funding
2hiring now
The Life Sciences market map of Switzerland: what these companies actually do
Breaks down the product sub‑categories and revenue models, noting 717 firms in enterprise tech and that physical commerce is the most common model with 603 companies.
- Enterprise Tech717 companies · $12.3B raised · 59 hiring
- Biopharmaceuticals272 companies · $8.5B raised · 23 hiring
- Medical Devices249 companies · $3.1B raised · 25 hiring
- Healthtech173 companies · $1B raised · 20 hiring
- Enterprise Software140 companies · $767.5M raised · 13 hiring
- Deep Tech132 companies · $2.4B raised · 13 hiring
- Consumer Digital96 companies · $670.2M raised · 7 hiring
- SaaS57 companies · $630.7M raised · 4 hiring
- Masschallenge Batches53 companies · $340.7M raised · 5 hiring
- Healthtech SaaS42 companies · $320.8M raised · 2 hiring
- Antibody Based Immunotherapy35 companies · $2.2B raised · 6 hiring
- In Vitro Diagnostics33 companies · $229.6M raised
Monetization
How Life Sciences companies make money
How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Physical Commerce603
E-Commerce - Product431
Subscription328
Fee-For-Service170
Commission on Transaction39
Advertising31
E-Commerce - Service9
Licensing2
Funding, M&A and the deals moving Life Sciences in Switzerland
Counts 677 corporate events over the past two years, including 137 funding rounds, 121 earnings releases, and 84 each for key‑person moves and mergers.
Funding 137Earnings 121Leadership 84M&A 84Announcement 62Contracts 41IPO 39Capital 24Board Updates 20Lawsuit 16
- M&ABoehringer Ingelheim forged a similar agreement with CDR-Life in November 2025, handing over up to $570m for the global rights to the latter’s trispecific autoimmune therapy, CDR111.2026-03-24
- FundingThe funding round is Rivia’s first since 2024, when it raised €3 million ($3.5 million) from backers Speedinvest, Amino Collective, and Nina Capital.2026-03-23
- FundingSunshine SwissCo GmbH, an affiliate of the EQT VIII fund (“EQT VIII”), together with other selling shareholders, is pleased to announce the completion of the placement of c. 34.0 million shares (the “Shares”) in Galderma Group AG (SIX: GALD) (“Galderma”) for aggregate gross proceeds of c. CHF 4.9 billion via an accelerated bookbuilding process (the “Placement”).2026-03-13
- FundingAlithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million. This additional funding brings the total seed round to CHF 6.9 million ($8.9 million).2026-03-04
- FundingPregnolia (2016, ZH) developed a medical device for the improvement of pregnancy care, which allows health care providers to measure the stiffness of the cervix for a more complete characterization of cervical status. The company has been selected as recipient of blended finance from EIC.2026-02-26
- FundingKellerhals Carrard advised Haelixa, as the Swiss deep-tech company has closed a pre-series A financing round. Verve Ventures and Zürcher Kantonalbank led the funding, with participation from impact-focused investor 212.2026-02-16
- M&ANew Delhi: Alkem Laboratories Limited announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has made a binding offer dated February 13, 2026, to acquire between 51% and 55% of the total issued equity share capital of Switzerland-based Occlutech Holding AG from certain existing shareholders.2026-02-16
- FundingBerlin Heals Holding AG, a MedTech company focused on transformative therapies for heart failure, today announced the successful closing of a new financing round, raising over 10M USD from a combination of existing shareholders and new investors.2026-02-12
- IPOSyngenta was reported to be planning for Hong Kong IPO after cancelling Shanghai IPO application in 2024 March to raise $9.1 billion with $60 billion enterprise value.2026-02-06
- FundingSequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it issued a subscription request notice in accordance with the terms of the share subscription facility agreement (the "Facility") entered into on 17 March 2025 between the Company and GEM Global Yield LLC SCS ("GEM"). Under the terms of the Facility, GEM has agreed, subject to certain conditions, to commit an amount of up to EUR 20 million in cash...2026-02-02
Mergers and acquisitions
Deals from the last 24 months where a Life Sciences company in Switzerland was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
| Acquirer | Target | Deal value | Status | Date |
|---|---|---|---|---|
| undisclosed | Pending | 2026-05-18 | ||
| $570M | Announced | 2026-03-24 | ||
| Alkem Medtech | undisclosed | Announced | 2026-02-16 | |
| undisclosed | Completed | 2026-01-16 | ||
| Matrix One | undisclosed | Completed | 2026-01-07 | |
| L’Oréal | undisclosed | Announced | 2026-01-06 |
Who is listing, hiring leaders, launching and winning work
Details specific events such as IPO filings, leadership changes, product launches, and contract wins for the sector’s companies.
IPO pipeline
17 companies listed or filing · last 24 months
SpeedelIPO · Swiss Stock Exchange · 2 reportsFeb 2025
Leadership moves
32 tracked people moves · last 12 months
Bioengineering AGMr. Jiang Pei · Appointment → Chief Executive OfficerApr 2026
AnaveonThaminda Ramanayake · Appointment → Chief Executive OfficerApr 2026
HaelixaPetri Alava · Appointment → Board MemberMar 2026
AscensiaPeter Bodlund · Appointment → President and CEOFeb 2026
Product launches
tracked launches · last 12 months
Nestlé Health ScienceNestlé NutreDec 2025
Contract wins
13 customer wins · last 24 months
Workforce actions
5 companies cutting roles · last 24 months
AC Immune~52 roles reported · cash runway extensionSep 2025
Addex Therapeutics~28 roles reported · cost reductionFeb 2025
Regulatory & litigation
14 regulatory events · 7 tracked suits · 24 months
Celsionapproved for Phase I clinical studies — FDAFeb 2025
- people in the US v syngentaexposure to paraquat pesticide causing Parkinson\'s disease · OngoingMar 2026
- bridgewood v moonlake immunotherapeuticsmisleading statements about drug trial results leading to investor losses · FiledNov 2025
Earnings pulse
companies reporting results · last 24 months
25 companies reporting130 company-quarters trackedbeat 22miss 9in line 4
Half of these companies grew revenue faster than +14.5%, half slower.
Who is building Life Sciences in Switzerland
Profiles 850 founders and CEOs across 560 firms, showing common alma maters like ETH Zurich (9) and frequent prior employers such as Boston Consulting Group (2).
Founders and chief executives12 of 850, from the best-funded companies on this page
Ex-Ridgeline Therapeutics, Black Diamond Therapeutics, Roche. University of Naples Federico II MD, TU Dresden PhD
Co-CEO-MindMaze · Ex-Bayer Pharmaceuticals, Voluntis, Sanofi · Sciences Po 1996, Paris Dauphine University - PSL 1998, HEC Paris 1998
Ex-Bobst. Stanford University BBA 2005, University of Friborg BA 2007
Co-Founder Flamboyant, Founder HIM, ex- CFO ARTEMIS Augenkliniken und med. Versorgungszentren, CFO AMEOS Group. University of Mannheim 2000…
CEO Syngenta Group, ex-CEO Nalco, Univar, DuPont. University of Delaware BE 1981
Xeltis, ex-The Medicines, ex-Profibrix, Maastricht University, 2004
Co-Founder Synple Chem. Trinity University BA 1996, Caltech PhD 1998
Noema Pharma, ex-Retrotope, ex-Medday Pharmaceuticals, Paris Descartes
Numab Therapeutics, ex-Numab, ex-Esbatech An Alcon Biomedical Research Unit, Biocenter, Basel, 2004
Where the founders studied
alma mater on record for 83 of 850 founders
ETH Zurich9
University of Zurich8
Harvard University7
INSEAD6
University of Cambridge6
Tel Aviv University4
Stanford University4
University of Oxford4
Where they worked before
a previous employer on record for 5 of 850 founders
Boston Consulting Group2
Bain1
Cisco1
Google1
Women and men among the founders
first names matched for 790 of 850 founders
17%
of matched founders are women
- women133
- men657
Inferred from first names, using 119 million people who state their own gender: a first name counts only where at least 20 of them share it and at least 90% of those share the same gender. The other 60 founders go in neither column.
Radar
Look up the people behind Life Sciences companies in Switzerland
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in Switzerland
Records 940 funding rounds since 2016 from 548 investors, with a typical round size of $2.5 million.
| Investor · most active investors since 2016 | Rounds | Led | Latest |
|---|---|---|---|
| Europa | 122 | — | Apr 2025 |
| Venture Kick | 84 | 27 | Feb 2026 |
| EIC Fund | 60 | — | Jun 2024 |
| Zurcher Kantonalbank | 53 | 6 | Mar 2026 |
| Verve Ventures | 28 | 12 | Feb 2026 |
| FIT | 27 | 2 | Oct 2025 |
| Schroders Capital | 20 | 2 | May 2025 |
| Fongit | 19 | 12 | Feb 2026 |
| Novo Holdings | 15 | 8 | May 2026 |
| HTGF | 15 | 4 | Feb 2026 |
Stage mix · rounds since 2016
Seed & Angel215
Series A–B223
Series C+ / PE80
Grants, debt & other422
The typical round is $2.5M — half were bigger, half smaller.
The biggest Life Sciences funding rounds in Switzerland
Highlights the largest disclosed round—ADC Therapeutics’ $200 million Series E—and lists ten other large recent rounds.
| Company | Round | Size | When | Backers |
|---|---|---|---|---|
| Series E | $200M | Oct 2017 | AstraZeneca, Auven Therapeutics, Redmile Group | |
| Series A | $200M | Jan 2025 | Novo Holdings, Orbimed, Blue Owl +6 more | |
| Series D | $181.4M | Nov 2024 | Orbimed, Novo Holdings, Jeito +5 more | |
| Series A | $180M | Feb 2019 | Andera Partners, NovaQuest Capital Management, Life Sciences Partners +4 more | |
| Series B | $165M | May 2026 | Orbimed, Novo Holdings, Blue Owl +10 more | |
| Series G | $150M | Nov 2025 | Revival Healthcare Capital | |
| Series F | $150M | Apr 2023 | Revival Healthcare Capital | |
| Series B | $130M | May 2025 | Novo Holdings, Catalio Capital Management, LifeArc Ventures +7 more | |
| Series D | $120M | Jan 2025 | — | |
| Series B | $118.9M | Dec 2021 | Forbion, Novartis Venture Fund, Pfizer Venture Investments +3 more |
Venture round sizes · 2023–2025
<$1M19
$1–10M52
$10–50M32
$50–250M25
>$250M0
128 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Seed$7.5MMay 2026
Post IPO$3.8MMay 2026
Seed$3.3MMay 2026
PEundisclosedMay 2026
- Seed$3.5MApr 2026
Series A$3.4MApr 2026
SeedundisclosedApr 2026
What the news says about Life Sciences in Switzerland
Counts 279,795 news articles in the last year, noting that coverage often focuses on international sports events and political relations.
News volume
Life Sciences coverage across Switzerland · articles per quarter
2021Q22026Q1
peak 199,636 in 2025Q3 · 279,795 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative)
202120232025
Positive-tone share moved 60% → 28%, negative 34% → 70% across 2021–2025.
What the coverage is about
The subjects that dominate Life Sciences news in Switzerland. The arrow shows whether each one is being written about more or less than a year ago.
- International sports competitions19,177→-6%
- Olympic games coverage11,427→+7%
- Soccer women's leagues and competitions10,360·
- International political relations10,056→-4%
- Sports coaching strategies8,301▲+3448%
- Youth sports development programs8,217▲+3403%
- Winter sports coverage7,169▲+16%
- Cryptocurrency impact on forex markets6,970▲+22%
- Championship event highlights6,205→-7%
- Soccer tournament competitions5,651▼-44%
Most-covered companies · last 12 months
- 200
- 155
- 49
- 48
- 41
- 36
- 32
- 32
- 26
- 23
100 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in Switzerland as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter
Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
tariff negotiations+211%free trade deals+232%trade dispute mechanisms+342%bilateral trade+326%diplomatic strategies+68%multilateral diplomacy+121%preferential tariff+161%trade barrier reduction+217%women\'s champions league+169%tariff rate quota+168%
europa league-82%quarterfinals-66%final match-78%final match recaps-54%multilateral accords-43%
The pressures the press keeps returning to
Three recurring angles in Switzerland Life Sciences coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk ▲ rising
142,547 articles touch this dimension · 40.4% critical tone
20212025
signals: tariff negotiations, free trade deals, monetary easing
Funding Momentum ▲ rising
27,125 articles touch this dimension · 38.0% critical tone
20212025
signals: currency intervention policies, inflation reports fx, trade deficits fx
Growth ▲ rising
40,030 articles touch this dimension · 31.7% critical tone
20212025
signals: gdp growth forex, inflation reports fx, currency intervention policies
Life Sciences jobs in Switzerland: who is hiring and what they ask for
Shows 221 job postings from 44 employers in the past year, with top‑required skills including BOM, CAD, type approval, microtechnology, and mechatronics.
221postings · last 12 months
833postings tracked overall
44employers advertising
Demand
The Skills Employers Ask For
What Life Sciences employers in Switzerland put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
- bom1▲
- cad1→
- type approval1▲
- microtechnology1▲
- mechatronics1▲
- mechanical design1▲
- functional testing1▲
- mechanical engineering1▲
- mechanical testing1▲
What level are these roles?
Entry12
Intern28
Senior87
Lead122
Manager168
Most advertised titles
- 22
- 13
- 11
- 10
- 9
- 9
What Life Sciences research is working on
Summarizes 53,147 academic papers, of which 4,958 identify common problems, 1,880 issue cautions, and 23,660 discuss opportunities.
How this field talks about itself
Life Sciences papers (gold) against all published research (grey)
Descriptive40.2% · 17.5%2.3×
Promising30.4% · 37.3%0.8×
Breakthrough14.1% · 26.0%0.5×
Problem-identifying8.3% · 9.7%0.9×
Cautionary3.5% · 4.7%0.7×
Comparative2.4% · 3.9%0.6×
Life Sciences literature runs 2.3× more “descriptive” than science at large (40.2% vs 17.5% baseline).
How the work is done
Empirical48.8%
Reviews37.2%
Methods-led11.2%
Position pieces2.2%
Theoretical0.6%
How the research reads
80% positive · 16% neutral · 4% negative, across 53,147 papers.
The institutions behind the field
- 87k
- 75k
- 61k
- 49k
- 43k
- 38k
ranked by how often their work is cited
Researchers who shaped it
Ahmad Almilaji · Reiki Nishimura · Tomofumi Osako · Yasuyuki Nishiyama · Rumiko Tashima · Masahiro Nakano · Glenn R. Gibson · Gregor Reid
The most-cited breakthroughs
- Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity · 9k cites
- In situ click chemistry generation of cyclooxygenase-2 inhibitors · 8k cites
- U1 snRNP regulates cancer cell migration and invasion in vitro · 7k cites
- Comprehensive molecular profiling of lung adenocarcinoma · 6k cites
- Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal · 6k cites
Common problems researchers identify4,503 papers · 7 recurring themes
Problems · theme 01
Sustainable Biofuel and Biomass Production
781 papers · 17.3% of this block
▲ +11% share2022→2025 share of research on this subject
Researchers discuss challenges in using microbes and plants for biofuel, biorefinery, and nutrient recycling.
Biofuel · Synthetic biology · Biomass · Biorefinery
“A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application”
781 of these papers raise it as a problem
Problems · theme 02
Food Safety and Processing Risks
757 papers · 16.8% of this block
▲ +41% share2022→2025 share of research on this subject
Papers highlight microbial hazards, processing impacts, and health implications of modern food products.
Food safety · Food processing · Food products · Human health
“Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures”
757 of these papers raise it as a problem
Problems · theme 03
Gene Expression and mRNA Therapeutics
711 papers · 15.8% of this block
▼ -32% share2022→2025 share of research on this subject
Studies examine mRNA, gene regulation, and cell‑culture methods for disease treatment and veterinary biosimilars.
Messenger RNA · Gene · Cell culture · Gene expression
“Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research”
711 of these papers raise it as a problem
Problems · theme 04
Crop Nutrition and Food Security
693 papers · 15.4% of this block
▲ +24% share2022→2025 share of research on this subject
Research focuses on fertiliser strategies, nutrient‑use efficiency, and germplasm improvement for secure food supplies.
Agriculture · Crop · Food security · Germplasm
“Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants”
693 of these papers raise it as a problem
Problems · theme 05
Plant Disease Management and Immunity
691 papers · 15.3% of this block
▲ +34% share2022→2025 share of research on this subject
Works address host‑pathogen interactions, fungicide use, and integrated pest‑management tactics.
Fungicide · Integrated pest management · Host · Disease management
“Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens”
691 of these papers raise it as a problem
Problems · theme 06
Antimicrobial Resistance Across Sectors
447 papers · 9.9% of this block
▲ +9% share2022→2025 share of research on this subject
Analyses cover resistance emergence in humans, livestock, and the environment and its broader impacts.
Antibiotic resistance · Antimicrobial · Antibiotics · Drug resistance
“Antimicrobial resistance in humans, livestock and the wider environment”
447 of these papers raise it as a problem
Problems · theme 07
Miscellaneous Biological and Chemical Topics
423 papers · 9.4% of this block
▼ -32% share2022→2025 share of research on this subject
A diverse set of papers explores unrelated biochemical, legal, and methodological subjects.
Order · NAD+ kinase · Human being · Sodium
“Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar”
423 of these papers raise it as a problem
Cautions1,765 papers · 7 recurring themes
Cautions · theme 01
Cellular Toxicity and Oxidative Stress Assays
379 papers · 21.5% of this block
▼ -21% share2022→2025 share of research on this subject
Investigations caution about in‑vitro and in‑vivo models for assessing microplastic and drug‑induced stress.
In vivo · Flow cytometry · In vitro · Oxidative stress
“Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells”
379 of these papers raise it as a problem
Cautions · theme 02
Genomic Selection and Sustainable Livestock Feeding
257 papers · 14.6% of this block
▲ +26% share2022→2025 share of research on this subject
Authors warn of complexities in breeding decisions and alternative protein sources for poultry.
Agriculture · Selection · Production · Trait
“Genomic selection in plant breeding: from theory to practice”
257 of these papers raise it as a problem
Cautions · theme 03
Feed Additives and Human Dietary Shifts
245 papers · 13.9% of this block
▼ -18% share2022→2025 share of research on this subject
Papers advise careful evaluation of bioactive feed compounds and plant‑protein substitution effects.
Feed additive · Animal feed · Feed conversion ratio · Health benefits
“Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production”
245 of these papers raise it as a problem
Cautions · theme 04
Food Contaminants and Regulatory Safety
240 papers · 13.6% of this block
▲ +16% share2022→2025 share of research on this subject
Research highlights potential hazards from caffeine, insect pigments, and other emerging food contaminants.
Food safety · Hygiene · Contamination · Food contaminant
“Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters”
240 of these papers raise it as a problem
Cautions · theme 05
DNA Damage and Repair Mechanisms
239 papers · 13.5% of this block
▼ -33% share2022→2025 share of research on this subject
Studies caution about interpreting gene‑expression changes linked to DNA repair and cancer diagnostics.
Gene · DNA damage · DNA repair · Gene expression
“Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations”
239 of these papers raise it as a problem
Cautions · theme 06
Co‑Selection of Antimicrobial Resistance
206 papers · 11.7% of this block
▲ +9% share2022→2025 share of research on this subject
Works stress the intertwined spread of antibiotic, biocide, and metal resistance in food‑borne microbes.
Antibiotic resistance · Antibiotics · Antimicrobial · Bacteria
“Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses”
206 of these papers raise it as a problem
Cautions · theme 07
Pesticide Resistance and Biological Control
199 papers · 11.3% of this block
▲ +13% share2022→2025 share of research on this subject
Authors discuss modeling pesticide dosing and the limits of fungal endophytes for pest management.
Pesticide · Integrated pest management · PEST analysis · Biological pest control
“The use of fungal entomopathogens as endophytes in biological control: a review”
199 of these papers raise it as a problem
Opportunities22,038 papers · 7 recurring themes
Opportunities · theme 01
Advanced Antibody and Imaging Techniques
1,044 papers · 17.4% of this block
▼ -19% share2022→2025 share of research on this subject
Opportunities arise from novel antibodies, fluorescence methods, and flow cytometry for in‑vivo studies.
Antibody · In vivo · Fluorescence · Flow cytometry
“Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom”
Opportunities · theme 02
Gene Modulation for Disease Therapy
1,032 papers · 17.2% of this block
▼ -28% share2022→2025 share of research on this subject
Research points to therapeutic potential of gene knockdown, apoptosis control, and cell‑growth regulation.
Downregulation and upregulation · Apoptosis · Gene knockdown · Cell growth
“Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc”
Opportunities · theme 03
Functional Plant‑Based Foods and Antioxidants
878 papers · 14.6% of this block
▲ +69% share2022→2025 share of research on this subject
Papers explore health‑promoting ingredients, bioactive compounds, and sustainable protein sources.
Health benefits · Functional food · Ingredient · Antioxidant
“Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives”
Opportunities · theme 04
Epigenetic Editing and RNA Diagnostics
823 papers · 13.7% of this block
▼ -33% share2022→2025 share of research on this subject
Studies reveal prospects for DNA‑methylation editing and sensitive miRNA detection platforms.
Gene · DNA methylation · Messenger RNA · DNA damage
“Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders”
Opportunities · theme 05
Novel Antimicrobials and Postbiotic Applications
809 papers · 13.5% of this block
▲ +24% share2022→2025 share of research on this subject
Research highlights plant‑derived antimicrobials and microbial metabolites improving animal health.
Antimicrobial · Antibiotic resistance · Biological pest control · Bacteria
“Plants as sources of new antimicrobials and resistance-modifying agents”
Opportunities · theme 06
Genetic Improvement of Crop Yield Traits
717 papers · 11.9% of this block
▼ -23% share2022→2025 share of research on this subject
Works focus on germplasm analysis, QTL mapping, and selection strategies to boost wheat productivity.
Germplasm · Trait · Quantitative trait locus · Selection
“Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield”
Opportunities · theme 07
Sustainable Biomass Conversion and Bioeconomy
697 papers · 11.6% of this block
▲ +31% share2022→2025 share of research on this subject
Papers present microbial fermentation and by‑product valorisation as routes to greener agriculture.
Biomass · Sustainability · Agriculture · Biofuel
“Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health”
Which of these themes are growing fastest
Tracks how the share of world research on different themes has changed between 2022 and 2025.
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Food Safety and Processing Risks▲+41%
Plant Disease Management and Immunity▲+34%
Crop Nutrition and Food Security▲+24%
Sustainable Biofuel and Biomass Production▲+11%
Antimicrobial Resistance Across Sectors▲+9%
Miscellaneous Biological and Chemical Topics▼-32%
Gene Expression and mRNA Therapeutics▼-32%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Genomic Selection and Sustainable Livestock Feeding▲+26%
Food Contaminants and Regulatory Safety▲+16%
Pesticide Resistance and Biological Control▲+13%
Co‑Selection of Antimicrobial Resistance▲+9%
Feed Additives and Human Dietary Shifts▼-18%
Cellular Toxicity and Oxidative Stress Assays▼-21%
DNA Damage and Repair Mechanisms▼-33%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Functional Plant‑Based Foods and Antioxidants▲+69%
Sustainable Biomass Conversion and Bioeconomy▲+31%
Novel Antimicrobials and Postbiotic Applications▲+24%
Advanced Antibody and Imaging Techniques▼-19%
Genetic Improvement of Crop Yield Traits▼-23%
Gene Modulation for Disease Therapy▼-28%
Epigenetic Editing and RNA Diagnostics▼-33%
Who files Life Sciences patents in Switzerland
Reports 42,279 patent filings from 2016‑2025 by about 8,000 organisations, with Hoffmann‑La Roche, Novartis, and Syngenta Participations as top filers.
42,279 filings 2016–20258,000 assigneespeak 4,828 in 2020
Filing momentum
patents published / year
20162025
Who files the most
- Hoffmann LA Roche14,664
- Novartis12,793
- Syngenta Participations3,095
- Baxalta2,066
- Genentech1,797
- UNIV Zuerich1,568
- Baxter Healthcare1,402
- Roche Glycart1,381
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
Keep going
Track Life Sciences in Switzerland beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news, research and patent trackers, covering Switzerland. Counts are of companies we track, not of every company that exists. Updated September 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.